(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

OBEONE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

OBEONE

ST13

US500000079197587

Class

5, 10

Filing

79197587

Registration

5494399

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

45

Latest update

03/06/2026

Trademark type

Word

Nice classes

5, 10

Filing date

07/29/2016

Registration date

06/19/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/03/2025

Last transaction

03/06/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

34

Owner location

F-92284 Suresnes Cedex, FR

Examiner

TRATOS, MARK STEVEN

Law office

M40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

BIOFARMA

Representatives

LISA GATES BAKER & MCKENZIE LLP

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the prevention and treatment of osteoporosis; sanitary products for medical purposessanitary towelssanitary napkinssanitary sterilizing preparations; implants for pharmaceutical useimplants comprising living tissuebiological implants in the nature of vital processed human or animal connective tissuemedical implants in the nature of implantable scaffolds comprising living tissue for maintaining tissue contour; implantable medicines for the prevention and treatment of diabetescardiovascular diseasesdiseases of the central nervous systemmetabolic disorderscancer; dietetic food substances adapted for medical use; food for babies; dietary supplementsenzyme food supplementsvitamin and mineral food supplementsherbal food supplements and trace element food supplements and dietetic food adapted for medical usepasta and crackersbarspowdered milkpollenamino acids and beverages; medical plasters used as material for dressings for medical purposes; materials used as wound dressing; medicated compresses for use in application of implants; teeth filling material; dental impression materials; disinfectants; preparations for destroying noxious animals; fungicidesherbicides; all the aforementioned goods for diabeticoncological and osteoporotic fields excluding veterinary products

Class 10

Medical apparatus and instruments for treating diabetesmedical apparatus and instruments for treating cancermedical apparatus and instruments for treating osteoporosis; applicators for medicinespatches sold without medication; medical implants sold without medication made of artificial material for delivering medicine; artificial surgical implantssurgical implants comprising artificial material; applicators for pharmaceutical preparationssubcutaneous applicators sold without medication for administering medicine; pumps for medical use for administering pharmaceutical products contained in receptacles; infusion pumps for administering medicines for medical purposesinjection devices for pharmaceutical products; pharmaceutical implants in the nature of drug delivery systems; holders for medical useholders specially adapted for placement of medical and surgical applicators; surgical apparatus and instruments; cases fitted for medical instruments; suture materials; scalpels; knives for surgical purposes; surgical knives; scissors for surgery; knives for surgical use; cases fitted for use by doctors; containers especially made for medical waste; containers for applying medicinesmedical fluid injectors and infusers; all the aforementioned goods for diabeticoncological and osteoporotic fields excluding apparatus and instruments for the veterinary field

Publications

History of USPTO decisions and trademark events.

45 publications found

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

03/05/2026

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

02/14/2026

INPC

INVALIDATION PROCESSED

02/14/2026

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

09/10/2025

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

09/03/2025

C71T

CANCELLED SECTION 71

01/03/2025

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

06/19/2023

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

10/12/2018

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/26/2018

FIMP

FINAL DISPOSITION PROCESSED

09/26/2018

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

09/19/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

06/19/2018

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

05/25/2018

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

05/09/2018

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

05/09/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/03/2018

PUBO

PUBLISHED FOR OPPOSITION

04/03/2018

GPNX

NOTIFICATION PROCESSED BY IB

03/30/2018

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

03/14/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/14/2018

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

03/14/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/01/2018

XAEC

EXAMINER'S AMENDMENT ENTERED

01/23/2018

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

01/23/2018

GNEA

EXAMINERS AMENDMENT E-MAILED

01/23/2018

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/23/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/22/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/21/2017

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

12/21/2017

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

08/16/2017

GNFR

FINAL REFUSAL E-MAILED

08/16/2017

CNFR

FINAL REFUSAL WRITTEN

08/16/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/29/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/29/2017

ALIE

ASSIGNED TO LIE

07/29/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/27/2017

RFNT

REFUSAL PROCESSED BY IB

01/12/2017

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

12/28/2016

RFRR

REFUSAL PROCESSED BY MPU

12/28/2016

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

12/23/2016

CNRT

NON-FINAL ACTION WRITTEN

12/22/2016

MAFR

APPLICATION FILING RECEIPT MAILED

12/20/2016

DOCK

ASSIGNED TO EXAMINER

12/15/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/15/2016

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/08/2016

Continuous trademark protection

Get notified about every new filing that threatens OBEONE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.